In the early 2000s, vancomycin cleared up nearly 100% of C. difficile cases but more recently that cure rate has dropped to 70%, researchers said. Photo by Adobe Stock/HealthDay News ...

Please provide your email address to receive an email when new articles are posted on . However, this finding did not reach statistical significance, the researchers noted. “This is the first ...

Crestone, Inc. ("Crestone") today announced recent publication in the leading infectious disease journal, The Lancet Infectious Diseases, of positive results from a Phase 2 clinical trial evaluating ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window WASHINGTON -- ...

Add Yahoo as a preferred source to see more of our stories on Google. In the early 2000s, vancomycin cleared up nearly 100% of C. difficile cases but more recently that cure rate has dropped to 70%, ...

Clostridium difficile is the most common cause of nosocomial diarrhea in acute-care settings. Until now, the two available therapies for C. difficile-associated diarrhea (CDAD), vancomycin and ...

Please provide your email address to receive an email when new articles are posted on . Fidaxomicin was the most rational fiscal strategy compared with vancomycin for Clostridium difficile-associated ...

Clostridioides difficile (C. difficile) is a leading cause of illness and death, especially for frail and hospitalized Americans. Now, a new study suggests that the leading antibiotic used to fight it ...

September 15, 2010 (Boston, Massachusetts) — Fidaxomicin is superior to vancomycin in treating recurrences of gastrointestinal Clostridium difficile infection, according to a blinded randomized trial ...

C. difficile infection recurrence rates were numerically lower with vancomycin than with placebo, though the difference was not significant. However, the results could be clinically meaningful, an ...

When I took antibiotics for a sinus infection, I began feeling weak and feverish, with diarrhea. I went to the ER and learned I had Clostridioides difficile, an infection in the large intestine. The ...

Vancomycin may reduce C. diff recurrence Prophylactic vancomycin twice per day has been effective in reducing the rate of C. difficile in high-risk patients aged 65 years and older. WASHINGTON — ...